| carbidopa/levodopa / Generic mfg. |
NCT05976737: Bioequivalence Study of Entacapone,Levodopa and Carbidopa Tablets in Healthy Chinese Subjects |
|
|
| Not yet recruiting | 1 | 68 | NA | Test (T) Entacapone,Levodopa and Carbidopa Tablets (II), Reference (R) Entacapone,Levodopa and Carbidopa Tablets (II) | The Affiliated Hospital of Qingdao University | Healthy | 09/23 | 07/24 | | |
STIMO-PHARMA, NCT04052776: Acute Effects of Pharmacological Neuromodulation on Leg Motor Activity in Patients With SCI Treated With EES |
|
|
| Completed | 1 | 3 | Europe | Buspirone, Levodopa-Carbidopa, Buspirone + Levodopa-Carbidopa, Placebo oral tablet | Centre Hospitalier Universitaire Vaudois, Ecole Polytechnique Fédérale de Lausanne | Spinal Cord Injuries, Drug Effect | 10/23 | 10/23 | | |
NCT06180720: Bioequivalence Study of Entacapone,Levodopa and Carbidopa Tablets in the Postprandial State in Healthy Chinese Subjects |
|
|
| Not yet recruiting | 1 | 36 | NA | Test (T) Entacapone,Levodopa and Carbidopa Tablets (II), Reference (R) Entacapone,Levodopa and Carbidopa Tablets (II) | The Affiliated Hospital of Qingdao University | Healthy | 01/24 | 11/24 | | |
NCT05471609: Sustained Release Oral Formulation for Treatment of Parkinson's Disease |
|
|
| Suspended | 1 | 6 | US | levodopa/carbidopa oral formulation A, levodopa/carbidopa oral formulation B, levodopa/carbidopa oral formulation C | University of Minnesota | Idiopathic Parkinson Disease | 06/25 | 06/25 | | |
